MARINUS PHARMACEUTICALS, INC. Long-Term Debt, Maturity, Year Two
MARINUS PHARMACEUTICALS, INC. had Long-Term Debt, Maturity, Year Two of $39.38 million as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2024-11-12
- 2024-09-30: Long-Term Debt, Maturity, Year Two $39.38M.
- 2024-06-30: Long-Term Debt, Maturity, Year Two $39.38M.
- 2024-03-31: Long-Term Debt, Maturity, Year Two $48.75M.
- 2023-12-31: Long-Term Debt, Maturity, Year Two $15.00M.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2024-09-30 | $39.38M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $39.38M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $48.75M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $15.00M 10-K · filed 2024-03-05 |
| 2023-09-30 | $15.00M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $15.00M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $15.00M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $11.25M 10-K · filed 2023-03-09 |
| 2022-09-30 | $11.25M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $11.25M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $11.25M 10-Q · filed 2022-05-12 |
| 2016-12-31 | $1.75M 10-K · filed 2017-03-13 |
| 2015-12-31 | $3.50M 10-K · filed 2016-03-07 |
| 2014-12-31 | $3.50M 10-K · filed 2015-03-12 |